MSD Ireland set to expand Carlow site

MSD Ireland (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)), is today announcing the creation of over 100 new jobs in Carlow as part of the company’s ongoing commitment to strengthening its manufacturing capabilities to meet increased global demand for MSD’s medicines and vaccines. The announcement comes as the company begins construction of a new facility at its existing site following a successful planning application process with Carlow County Council.

The new, state-of-the-art facility will be a first of its kind globally, focussing on the production of next generation oncology biologics. Currently employing almost 530 staff, MSD Carlow opened in 2008 as MSD’s first vaccines facility outside of the US. Construction on the site and hiring for open positions will commence immediately, with the intention of starting the new manufacturing operations in 2025. 

The proposed facility will employ an additional 100 permanent staff in addition to the 700 roles created during construction. When operational, the new roles will include highly skilled jobs in quality, operations, engineering, supply chain and technical support.  

Click here to read original article ...